UCSF Neurosurgery

@neurosurgucsf.bsky.social

Department of Neurological Surgery @ucsanfrancisco.bsky.social. We focus on providing the best possible care for our patients, alongside research efforts to develop better treatments. neurosurgery.ucsf.edu

New research led by Rongze "Olivia" Lu, PhD, shows that inhibiting protein phosphatase 2A (PP2A) induces a form of cellular senescence that enhances antitumor immunity in preclinical models of medulloblastoma. braintumorcenter.ucsf.edu/news/turning... @parkerici.bsky.social @ucsfcancer.bsky.social

JCI - Protein phosphatase 2A regulates senescence and immunogenicity in medulloblastoma models

doi.org

Journal of Clinical Investigation@jci.org · last mo.

Proposing a new approach for aggressive, treatment-resistant pediatric brain tumors. Rongze Olivia Lu & team @neurosurgucsf.bsky.social target protein phosphatase 2A (PP2A) to induce tumor cell senescence and boost immune response in medulloblastoma models: doi.org/10.1172/JCI1... #medulloblastoma

Super excited to share our new study showing that deep brain stimulation (DBS) can be synchronized to each step a person takes and improve walking in Parkinson’s disease patients!

UCSF Neurosurgery@neurosurgucsf.bsky.social · 2mo ago

New in @natmed.nature.com, work by @doriswang.bsky.social shows that distinct left- and right-leg swing biomarkers can drive DBS that changes on a sub-second timescale with each step. A major advance toward movement-driven, precision-timed neuromodulation for Parkinson’s disease. 🧠📈 rdcu.be/fopFJ